Events & Conferences

In this section, explore the key scientific events and conferences where Clinisciences takes center stage—whether as a sponsor or an active participant. From high-impact international congresses to focused expert symposia, our presence reflects our dedication to advancing research and connecting with the scientific community. These events are more than just dates on a calendar—they're opportunities to exchange ideas, showcase innovative tools, and stay at the forefront of scientific discovery. Join us where breakthroughs happen!

Lab Innovations

Lab Innovations es el evento líder en el Reino Unido en tecnología, análisis y aplicaciones de laboratorio para todos los sectores.

IndAc25 Conference

Join us at the SULSA IndAc25 Conference on 28–29 October 2025 at the Technology and Innovation Centre in Glasgow — a unique opportunity to explore the future of life sciences through innovation, collaboration, and career development.

37ᵗʰ AICC International Meeting – “Trick or Treat?”

The 37ᵗʰ AICC International Meeting – “Trick or Treat?” will be held from 27th to 29th October 2025 at the Auditorium CTO AOU Careggi, University of Florence, Florence, Italy, bringing together researchers, clinicians, and industry stakeholders to explore advances in therapy response and resistance and to promote personalized medicine.

8th BraYn Conference 2025

The 8ᵗʰ BraYn Conference 2025 will take place from 29th to 31st October at the Aula Magna ‘Giovanni Agnelli’, Politecnico di Torino, Italy, bringing together early-career neuroscientists, researchers, and clinicians to explore the latest advances in neuroscience and foster interdisciplinary collaboration and clinical innovation.

Press Release: Genexpath joins Quimigen Group

Quimigen refuerza su liderazgo en biología molecular y hemato-oncología con la adquisición estratégica de Genexpath, especialista en soluciones de diagnóstico in vitro para linfomas y sarcomas.

Comunicado de prensa : Oncomedics se une al Grupo Quimigen

Quimigen Group, distribuidor europeo de reactivos y equipos para la investigación científica y el diagnóstico médico, ha adquirido Oncomedics, empresa francesa de biotecnología especializada en la personalización de tratamientos contra el cáncer.